BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 35181201)

  • 1. The extended concurrent genes signature for disease-free survival in breast cancer.
    Huang CS; Tsai ML; Lu TP; Tu CC; Liu CY; Huang CJ; Ho YS; Tu SH; Chuang EY; Tseng LM; Huang CC
    J Formos Med Assoc; 2022 Oct; 121(10):1945-1955. PubMed ID: 35181201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent gene signatures for han chinese breast cancers.
    Huang CC; Tu SH; Lien HH; Jeng JY; Huang CS; Huang CJ; Lai LC; Chuang EY
    PLoS One; 2013; 8(10):e76421. PubMed ID: 24098497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
    Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
    Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer concurrent gene signature based on coherent patterns between genomic and transcriptional alterations.
    Shen MH; Huang CJ; Ho TF; Liu CY; Shih YY; Huang CS; Huang CC
    BMC Cancer; 2022 May; 22(1):590. PubMed ID: 35637462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
    Mo W; Ding Y; Zhao S; Zou D; Ding X
    PLoS One; 2020; 15(11):e0241924. PubMed ID: 33170908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micro-scale genomic DNA copy number aberrations as another means of mutagenesis in breast cancer.
    Chao HH; He X; Parker JS; Zhao W; Perou CM
    PLoS One; 2012; 7(12):e51719. PubMed ID: 23284754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of ultra-dense array CGH analysis for the discovery of micro-copy number alterations and gene fusions in the cancer genome.
    Przybytkowski E; Ferrario C; Basik M
    BMC Med Genomics; 2011 Jan; 4():16. PubMed ID: 21272361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast.
    Hawthorn L; Luce J; Stein L; Rothschild J
    BMC Cancer; 2010 Aug; 10():460. PubMed ID: 20799942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.
    Yau C; Fedele V; Roydasgupta R; Fridlyand J; Hubbard A; Gray JW; Chew K; Dairkee SH; Moore DH; Schittulli F; Tommasi S; Paradiso A; Albertson DG; Benz CC
    Breast Cancer Res; 2007; 9(5):R59. PubMed ID: 17850661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refinement of breast cancer risk prediction with concordant leading edge subsets from prognostic gene signatures.
    Huang CC; Tu SH; Lien HH; Huang CS; Huang CJ; Lai LC; Tsai MH; Chuang EY
    Breast Cancer Res Treat; 2014 Sep; 147(2):353-70. PubMed ID: 25158930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A discovery resource of rare copy number variations in individuals with autism spectrum disorder.
    Prasad A; Merico D; Thiruvahindrapuram B; Wei J; Lionel AC; Sato D; Rickaby J; Lu C; Szatmari P; Roberts W; Fernandez BA; Marshall CR; Hatchwell E; Eis PS; Scherer SW
    G3 (Bethesda); 2012 Dec; 2(12):1665-85. PubMed ID: 23275889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
    Sørlie T; Wang Y; Xiao C; Johnsen H; Naume B; Samaha RR; Børresen-Dale AL
    BMC Genomics; 2006 May; 7():127. PubMed ID: 16729877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a novel CNV-related prognostic signature predicting prognosis in patients with breast cancer.
    Hu W; Li M; Zhang Q; Liu C; Wang X; Li J; Qiu S; Li L
    J Ovarian Res; 2021 Aug; 14(1):103. PubMed ID: 34364397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual risk stratification of Taiwanese breast cancers following curative therapies with the extended concurrent genes signature.
    Huang CS; Lu TP; Liu CY; Huang CJ; Chiu JH; Chen YJ; Tseng LM; Huang CC
    Breast Cancer Res Treat; 2021 Apr; 186(2):475-485. PubMed ID: 33392837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Potential Biomarkers From Hepatocellular Carcinoma With MT1 Deletion.
    Zhang R; Huang M; Wang H; Wu S; Yao J; Ge Y; Lu Y; Hu Q
    Pathol Oncol Res; 2021; 27():597527. PubMed ID: 34257549
    [No Abstract]   [Full Text] [Related]  

  • 16. Reference-unbiased copy number variant analysis using CGH microarrays.
    Ju YS; Hong D; Kim S; Park SS; Kim S; Lee S; Park H; Kim JI; Seo JS
    Nucleic Acids Res; 2010 Nov; 38(20):e190. PubMed ID: 20802225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
    Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
    Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of fetal submicroscopic chromosomal abnormalities in failed array CGH samples: copy number by sequencing as an alternative to microarrays for invasive fetal testing.
    Cohen K; Tzika A; Wood H; Berri S; Roberts P; Mason G; Sheridan E
    Ultrasound Obstet Gynecol; 2015 Apr; 45(4):394-401. PubMed ID: 25510919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal adenocarcinoma.
    Goh XY; Rees JR; Paterson AL; Chin SF; Marioni JC; Save V; O'Donovan M; Eijk PP; Alderson D; Ylstra B; Caldas C; Fitzgerald RC
    Gut; 2011 Oct; 60(10):1317-26. PubMed ID: 21478220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative Prognostic and Predictive Value of Gene Signature and Histologic Grade in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
    Iwamoto T; Kelly C; Mizoo T; Nogami T; Motoki T; Shien T; Taira N; Hayashi N; Niikura N; Fujiwara T; Doihara H; Matsuoka J
    Clin Breast Cancer; 2016 Apr; 16(2):95-100.e1. PubMed ID: 26631838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.